#

Small caps

: 1143
A Cathie Wood ETF has invested in Scribe, a clinical-stage developer of gene therapies for heart diseases / Photo: Facebook / ARK Invest
Small Caps·
Small caps last week: Cathie Wood’s Scribe bet, deals to acquire Forte Bio and CBIZ
The record cybersecurity and IT modernization government contract is expected to add more than $5 million in annual recurring revenue for Cycurion / Photo: Cycurion
Small Caps·
IT small cap Cycurion soars 500% after landing biggest contract in its history
Apnimed raised $192 million in an upsized U.S. IPO, priced at the top of a marketed range / Photo: LinkedIn / Apnimed
Small Caps·
+1
·
Apnimed IPO: Sleep apnea drug developer debuts on the Nasdaq
Arras explored Besshoky, a prospective mining site in Kazakhstan, with Teck Resources / Photo: X / Arras Minerals
Small Caps·
Analysts like Canadian miner Arras for low-cost Kazakhstan copper and gold potential
CBIZ agreed to be taken private by Grant Thornton in a more than $3 billion cash deal / Photo: Facebook / cbizservices
Small Caps·
Prof. services adviser CBIZ to be acquired by peer in largest such deal in 25 years
Shares of the micro cap slumped on the share sale / Photo: Unsplash / Hans Reniers
Small Caps·
Micro-cap biotech Processa acquires immune-focused Vidya, announces share sale
Noble Capital Markets argues Beasley is building a more resilient local media platform / Facebook / BeasleyMedia
Small Caps·
Noble is first on Wall St. to cover Beasley Broadcast Group, seeing almost 50% upside
The move was said to reflect the companys intention to divest noncore assets as it concentrates on its core payments and financial infrastructure businesses / Photo: YouTube screenshot / NYSE
Small Caps·
PSQ Holdings, with Trump son as an investor, jumps 20% on sale of part of business
Canadas Telesat has plans for a 198-satellite constellation that will provide additional resiliency for a network designed to deliver around 10 terabits per second of capacity for business and government users / Photo: X / Telecom
Small Caps·
After July pares some of their 1H26 gains, what is the outlook for space small caps?
The deal adds Forte’s experimental drug FB102, which Argenx said has potential to address multiple autoimmune diseases / Photo: Unsplash / CDC
Small Caps·
Autoimmune-focused biotech Forte to be acquired by Argenx; stock soars 40%
Freedom Broker has initiated on Intrepid with a buy rating / Photo: Facebook / IntrepidPotash
Small Caps·
Freedom Broker is first on Wall St. to issue 'buy' on U.S. potash producer Intrepid
A Cathie Wood ETF has invested in Scribe, a clinical-stage developer of gene therapies for heart diseases / Photo: LinkedIn / Catherinedwood
Small Caps·
Cathie Wood's ARK Genomic Revolution ETF buys newly public biotech Scribe
Load more